Literature DB >> 20453663

Plasma prolactin level and risk of incident hypertension in postmenopausal women.

Luxia Zhang1, Gary C Curhan, John P Forman.   

Abstract

BACKGROUND: Laboratory and cross-sectional human studies suggest a potential role for prolactin in the pathogenesis of hypertension; however, the prospective association between prolactin and hypertension has not been previously reported.
METHODS: We prospectively examined the association between daytime plasma prolactin levels and the risk of incident hypertension among 874 postmenopausal women who were participants of the Nurses' Health Study. Cox proportional hazards regression models were used to adjust for potential confounders.
RESULTS: We identified 183 incident cases of hypertension during 8 years of follow-up. After adjusting for potential confounders, the relative risk of hypertension for a 1-standard deviation higher plasma prolactin was 1.31 (95% confidence interval 1.05-1.62). Compared with women with plasma prolactin levels of 8.0 ng/ml or below, the multivariable relative risk of incident hypertension for those with prolactin levels above 8.0 ng/ml was 1.34 (95% confidence interval 0.90-1.99).
CONCLUSION: A higher daytime plasma prolactin level is independently associated with an increased risk of incident hypertension among postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453663      PMCID: PMC3139424          DOI: 10.1097/HJH.0b013e328339f254

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  27 in total

Review 1.  Total energy intake: implications for epidemiologic analyses.

Authors:  W Willett; M J Stampfer
Journal:  Am J Epidemiol       Date:  1986-07       Impact factor: 4.897

2.  Prolactin-induced expression of intercellular adhesion molecule-1 and the accumulation of monocytes/macrophages during regression of the rat corpus luteum.

Authors:  K K Olson; D H Townson
Journal:  Biol Reprod       Date:  2000-06       Impact factor: 4.285

3.  Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis.

Authors:  S H Hou; S Grossman; M E Molitch
Journal:  Am J Kidney Dis       Date:  1985-10       Impact factor: 8.860

4.  2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.

Authors:  Judith A Whitworth
Journal:  J Hypertens       Date:  2003-11       Impact factor: 4.844

5.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

6.  Moderate alcohol intake and renal function decline in women: a prospective study.

Authors:  Eric L Knight; Meir J Stampfer; Eric B Rimm; Susan E Hankinson; Gary C Curhan
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992

7.  Relationship between serum prolactin concentration, vascular angiotensin sensitivity and arterial blood pressure during third trimester pregnancy.

Authors:  T Oney; O Bellmann; H Kaulhausen
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

8.  Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.

Authors:  K O Stumpe; R Kolloch; M Higuchi; F Krück; H Vetter
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

9.  Modulation of tissue responsiveness to angiotensin-II in hyperprolactinemic subjects.

Authors:  B M Arafah; N H Gordon; R Salazar; J G Douglas
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

10.  Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women.

Authors:  G A Colditz; P Martin; M J Stampfer; W C Willett; L Sampson; B Rosner; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1986-05       Impact factor: 4.897

View more
  11 in total

1.  Evidence for hyperprolactinemia in migraineurs: a systematic review and meta-analysis.

Authors:  Ali Noori-Zadeh; Morvarid Karamkhani; Ali Seidkhani-Nahal; Afra Khosravi; Shahram Darabi
Journal:  Neurol Sci       Date:  2019-08-23       Impact factor: 3.307

2.  Prolactin alters blood pressure by modulating the activity of endothelial nitric oxide synthase.

Authors:  Albert S Chang; Ruriko Grant; Hirofumi Tomita; Hyung-Suk Kim; Oliver Smithies; Masao Kakoki
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

3.  Prolactin as a predictor of endothelial dysfunction and arterial stiffness progression in menopause.

Authors:  G Georgiopoulos; I Lambrinoudaki; F Athanasouli; E Armeni; A Koliviras; A Augoulea; D Rizos; C Papamichael; A Protogerou; K Stellos; K Stamatelopoulos
Journal:  J Hum Hypertens       Date:  2017-03-23       Impact factor: 3.012

4.  Duration of lactation and incidence of maternal hypertension: a longitudinal cohort study.

Authors:  Alison M Stuebe; Eleanor B Schwarz; Karen Grewen; Janet W Rich-Edwards; Karin B Michels; E Michael Foster; Gary Curhan; John Forman
Journal:  Am J Epidemiol       Date:  2011-10-12       Impact factor: 4.897

5.  Association Between Prolactin and Incidence of Cardiovascular Risk Factors in the Framingham Heart Study.

Authors:  Kate E Therkelsen; Tobin M Abraham; Alison Pedley; Joseph M Massaro; Patrice Sutherland; Udo Hoffmann; Caroline S Fox
Journal:  J Am Heart Assoc       Date:  2016-02-23       Impact factor: 5.501

6.  Association between serum prolactin levels and insulin resistance in non-diabetic men.

Authors:  Makoto Daimon; Aya Kamba; Hiroshi Murakami; Satoru Mizushiri; Sho Osonoi; Masato Yamaichi; Kota Matsuki; Eri Sato; Jutaro Tanabe; Shinobu Takayasu; Yuki Matsuhashi; Miyuki Yanagimachi; Ken Terui; Kazunori Kageyama; Itoyo Tokuda; Ippei Takahashi; Shigeyuki Nakaji
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

7.  Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysis.

Authors:  Sarah Byberg; Jesper Futtrup; Mikkel Andreassen; Jesper Krogh
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

Review 8.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

9.  A prospective population-based cohort study of lactation and cardiovascular disease mortality: the HUNT study.

Authors:  Tone Natland Fagerhaug; Siri Forsmo; Geir Wenberg Jacobsen; Kristian Midthjell; Lene Frost Andersen; Tom Ivar Lund Nilsen
Journal:  BMC Public Health       Date:  2013-11-13       Impact factor: 3.295

Review 10.  Recent advances in central cardiovascular control: sex, ROS, gas and inflammation.

Authors:  Pauline M Smith; Alastair V Ferguson
Journal:  F1000Res       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.